상세 보기
Cost Effectiveness and Resource Allocation
ISSN
P 1478-7547
출판사
BioMed Central
국가
ENGLAND
발행 상태
활성
데이터베이스 수록 정보
DOAJ 2017-2021 (5년)
EMBASE 2016-2020 (5년)
JCR 2016-2019 (4년)
Scopus 2017-2020 (4년)
SJR 2004-2019 (16년)
SSCI 2016-2021 (6년)
전체 3건 중 1번부터 3번까지의 결과를 표시합니다.
2026
Article
Carfilzomib, pomalidomide, and dexamethasone for multiple myeloma after carfilzomib, lenalidomide, and dexamethasone
- Yi, Jun Ho ;
- Park, Sung-Soo ;
- Min, Chang-Ki ;
- Lee, Jae Hoon ;
- Eom, Hyeon-Seok ;
- 외 2명
- 2026-01
- International Journal of Hematology
- SPRINGER JAPAN KK
2021
Article
Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial
- Choi, Eun-Ji ;
- Lee, Je-Hwan ;
- Kim, Hawk ;
- Choi, Yunsuk ;
- Lee, Won-Sik ;
- 외 5명
- 2021-06
- International Journal of Hematology
- SPRINGER JAPAN KK
Article
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
- Lee, H.S. ;
- Kim, K. ;
- Lee, J.-J. ;
- Yoon, S.-S. ;
- Bang, S.-M. ;
- ... Lee, J.H. ;
- 외 18명
- 2021-01
- International Journal of Hematology
- SPRINGER JAPAN KK